|
2025
|
P/S
|
Vaccines for human use |
|
2024
|
Invention
|
Methods for preventing dengue and hepatitis a.
The invention relates to a method for preventing ... |
|
|
Invention
|
A method for determining the concentration of residual vero cell genomic dna in a sample containi... |
|
|
Invention
|
Protective device for a hose connection of a vaccine bag. The invention relates to a protective d... |
|
|
Invention
|
Coadministration of tetravalent dengue vaccine with hpv vaccine. The invention relates to a HPV v... |
|
|
Invention
|
Dengue outbreak prediction. A computer-implemented method of providing a dengue data platform for... |
|
|
Invention
|
Compositions and methods of vaccination against dengue virus in children and young adults.
Embod... |
|
|
Invention
|
Compositions and methods for dengue virus chimeric constructions in vaccines.
Embodiments herein... |
|
|
Invention
|
Methods of detection and removal of rhabdoviruses from cell lines. The present disclosure relates... |
|
|
Invention
|
Method for inactivating zika virus and for determining the completeness of inactivation.
The pre... |
|
2023
|
Invention
|
Large-scale flaviviral vaccine production and manufacture. The present invention provides methods... |
|
|
Invention
|
A method for the quantitative determination of human serum albumin monomer in virus-containing ph... |
|
|
Invention
|
A method for determining the proportion of a live, attenuated flavivirus having a nucleotide sequ... |
|
|
Invention
|
A method for determining the infectivity of a virus. The present invention relates to a method fo... |
|
|
Invention
|
Method of conferring a protective immune response to norovirus.
The present invention relates to... |
|
|
Invention
|
A method for detecting the presence of a dengue virus serotype in a sample containing at least on... |
|
|
Invention
|
Dengue vaccine formulation. The present invention relates to a dengue vaccine formulation compris... |
|
|
Invention
|
Use of dengue vaccine in pregnant and/or breastfeeding subjects. A dengue vaccine for use in a me... |
|
|
Invention
|
Zika vaccines and immunogenic compositions, and methods of using the same.
The present disclosur... |
|
|
Invention
|
Anti-denv3 antibodies. The present invention relates to anti-dengue virus serotype 3 (DENV3) anti... |
|
|
Invention
|
Computer-implemented determination of cell confluence.
A computer-implemented method of determin... |
|
|
Invention
|
Computer-implemented determination of cell confluence. A computer-implemented method of determini... |
|
|
Invention
|
Method for inactivating zika virus and related methods.
The present disclosure relates to method... |
|
|
Invention
|
Zika vaccines and immunogenic compositions, and methods of using the same. The present disclosure... |
|
|
Invention
|
Parenteral norovirus vaccine formulations.
The present invention relates to single dose parenter... |
|
|
P/S
|
Vaccines, excluding vaccines against meningitis |
|
|
Invention
|
Computer-based determination of flavivirus infectivity.
A computer-implemented method of determi... |
|
|
Invention
|
Computer-based determination of flavivirus infectivity. A computer-implemented method of determin... |
|
|
Invention
|
Compositions and methods for stabilizing flaviviruses with improved formulations.
Embodiments he... |
|
|
Invention
|
Dengue vaccine batch mixing process.
The present invention relates to a batch mixing process for... |
|
|
Invention
|
Dengue vaccine batch mixing process. The present invention relates to a batch mixing process for ... |
|
|
Invention
|
Large-scale flaviviral vaccine production and manufacture.
The present invention provides method... |
|
|
Invention
|
Dengue vaccine unit dose and administration thereof.
The invention relates to a single unit dose... |
|
2022
|
Invention
|
Methods and kits for determining the presence and/or amount of a human igg3 antibody specific for... |
|
|
Invention
|
Pharmaceutical packaging |
|
|
Invention
|
Methods for determining norovirus-reactive antibodies.
The present disclosure is directed to met... |
|
|
Invention
|
Immunofocus assay for determining the titer of dengue viruses.
The present invention provides im... |
|
|
Invention
|
Dengue vaccine unit dose and administration thereof.
The invention relates to a unit dose of a d... |
|
|
Invention
|
Solid composition, freeze-drying method and glass vial.
The present invention is directed to a s... |
|
|
Invention
|
Methods for characterizing the immune response of a subject to a dengue virus composition.
The p... |
|
|
Invention
|
Zika vaccines and immunogenic compositions, and methods of using the same. e.g.,e.g., wherein the... |
|
2021
|
Invention
|
Methods for determining complement-fixing antibodies.
The invention relates to methods for deter... |
|
|
Invention
|
Method for detection of zika virus specific antibodies.
The present invention is directed to a m... |
|
|
Invention
|
Qualitative and quantitative determination of single virus haplotypes in complex samples.
The pr... |
|
|
Invention
|
Method for removing host cell dna from virus preparation.
The present invention relates to a met... |
|
2020
|
P/S
|
Vaccines for human use. |
|
|
P/S
|
Vaccins à usage humain. |
|
2019
|
P/S
|
Human vaccines, excluding vaccines against meningitis. |
|
|
P/S
|
Vaccines, excluding vaccines against meningitis. |
|
2018
|
P/S
|
Vaccines for human use |
|
2016
|
P/S
|
Vaccines for human use, namely vaccines against dengue fever. |
|
2015
|
P/S
|
Vaccines for human use, namely, vaccines against dengue
fever. |
|
|
P/S
|
Vaccines for human use, namely vaccines against dengue fever |
